Skip to main content
Premium Trial:

Request an Annual Quote

Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

NEW YORK ─ Vela Diagnostics said on Wednesday that it has received Emergency Use Authorization from the US Food and Drug Administration for its ViroKey SARS-CoV-2 RT-PCR Test v2.0.

The automated probe-based RT-PCR test detects SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs and is optimized for a workflow consisting of Vela Diagnostics' Sentosa SX101 and Sentosa SA201 instruments. The test enables high-throughput testing of up to 46 samples in a single run with reduced hands-on time, Vela said.

In August, the Singapore-based company received FDA EUA for a manual version of the ViroKey SARS-CoV-2 RT-PCR Test.

Rachel Yap, product manager at Vela, said in an email that the new test is multiplexed, targeting the virus' ORF1a and N genes, and has a better limit of detection than the manual version, in addition to providing automated analysis and reporting of results.

The firm said it has also received provisional authorization for use of the test from the Singapore Health Sciences Authority.

In July, Vela announced it had received CE marking for the automated test. In April, it received CE marking for the nonautomated version.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.